Abveris, Saccharo partner on antibody discovery

By The Science Advisory Board staff writers

December 3, 2020 -- Abveris has entered into an antibody discovery partnership with Saccharo for the discovery of monoclonal antibodies to advance Saccharo's immuno-oncology therapeutic pipeline.

Under the agreement, Abveris will utilize its DiversimAb mouse model in combination with its next-generation B-cell screening platform (powered by Berkeley Lights Beacon) to rapidly discover monoclonal antibodies. In return for its services, Abveris will receive compensation partially in the form of equity.


Copyright © 2020 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.